Translumina
Exploring Limitless Possibilities for Life
Since 2010, Translumina Therapeutics has been dedicated to transforming the landscape of coronary care. As a pioneering company in the manufacture and distribution of coronary intervention devices, we believe in the mission of “Exploring Limitless Possibilities for Life.”
At Translumina Therapeutics, we specialize in producing best-in-class drug-eluting stents that set the benchmark for quality and performance in the market. Our commitment to excellence extends beyond manufacturing; we take pride in introducing cutting-edge technologies for coronary intervention procedures to the Indian market, ensuring that advanced medical solutions are accessible where they are needed most.
Executive Leadership
Board of Directors
Gurmit Singh Chugh
Co-Founder and Chairman
Punita Sharma Arora
Co-Founder and Vice Chairman
Avnish Mehra
Vice Chairman, Private Equity – Everstone Capital
Arjun Oberoi
Managing Director – Everstone Capital
Vishal Sharma
Managing Director - Everstone Capital
Vishal Goenka
Executive Director - Everstone Capital
Indranil Mukherjee
Group CEO
Gurmit Singh Chugh
Co-Founder and Chairman
Executive Leadership Team
Indranil Mukherjee
Group CEO
Kewal Jindal
Group CFO
Paritosh Arora
CEO – India Business
Kalyan Bhowal
VP – Operations, India
Satyakam Mishra
CHRO
Eric Kumpa
MD – Translumina Gmbh
Michael Stöver
Global Head – R&D
Ingrid Frank
CEO – LaMed Gmbh
Our Journey of Medical Innovation
and Global Expansion
Translumina journey reflects a steadfast commitment to advancing medical technology and transforming patient care worldwide. With an expanding portfolio of innovative cardiovascular devices and a strong global presence, we build on India’s healthcare heritage while contributing to medical progress across continents. Our collaboration with the German Heart Centre exemplifies our dedication to pioneering advancements in cardiovascular care, setting benchmarks for quality and excellence in patient outcomes.
Translumina
Incorported
Launch of
YUKON DES technology
Collaborated with ASAHI Intecc, Japan
2014
Launched Complete portfolio for Vascular Access solutions
2016
Partnered with
Kaneka, Japan
Launched VIVO ISAR, World’s First
Polymer Free Dual Drug DES
World’s First Ultra High Pressure Balloon OPN NC, SIS Medical, Switzerland
2018
Acquired Translumina
GmbH, Germany
Acquired Artic GmbH,
Germany & Partnership with
Everstone Capital, Singapore
Launched Shockwave IVL, USA
2020
Asia’s largest laser cutting facility in Dehradun
2021
Asia’s largest manufacturing facility for Heart Valves in AMTZ,Vizag
Launch of ISAR SUMMIT
Everolimus Eluting Polymer free DES
Imaging Solutions with
ACIST, USA
Direct Operations in UAE
Translumina
Group Companies
Translumina is strengthened by its association with Lamed Healthcare and Blue Medical Devices, both leaders in their respective fields. With over 30 years of expertise, Lamed focuses on high-quality, scientifically proven innovations, particularly in vascular and cardiac surgery and stent grafts, striving for impactful advancements in healthcare. Blue Medical, based in the Netherlands, specializes in advanced drug-coated balloon technologies for complex coronary interventions, enhancing safety and efficacy in cardiovascular treatments. Together, our group companies embody a shared commitment to quality, innovation, and global healthcare solutions.
